Becton, Dickinson and Company · BDX · Next earnings

Becton, Dickinson and Company reports Thursday, Nov 5, 2026

BDX reports before market open with consensus EPS at $4.06 and revenue at $5.11B. Last quarter: BDX Beats on EPS and Revenue, Raises Full-Year Guidance Amid Core Platform Strength

Reports Before market open46 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $4.06 Calendar consensus
Consensus revenue $5.11B Calendar consensus
Report date Nov 5, 2026 Thursday, date estimated
Session Before market open 46 days away

Where BDX left off: FY2026 Q2

Full report

BDX Beats on EPS and Revenue, Raises Full-Year Guidance Amid Core Platform Strength

EPS surprise +4.3% Reported $2.90 vs $2.78
Revenue surprise +0.9% Reported $4.71B vs $4.67B
Stock move +5.9% Event window
Subsequent drift -1.4% Up to 20 sessions

Management raised full-year adjusted EPS guidance to $12.52-$12.72, up from prior expectations. Guidance sentiment on the call was characterized as raised, and management tone was confident. Revenue grew 2.6% year-over-year to $4.714B with an adjusted operating margin of 24.2%.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Continued pressure from Alaris pump upgrade cycle and vaccine demand weakness.
  • Regulatory risk from FDA warning letter and potential extended ship hold at El Paso.
  • Tariff impacts and raw-material cost volatility affecting oil and resin inputs.
  • Headwinds in the China market due to value-based procurement dynamics.
  • Potential competition from oral GLP-1 therapies affecting biologic drug delivery growth.

Questions analysts left open

  • Sustainability of TSA and other income items noted in Q2.
  • Margin outlook amid tariffs and inflation pressures.
  • Timeline and impact of the Alaris remediation and headwinds.
  • Depth and duration of the vaccine market slowdown.
  • Effectiveness of resin and oil hedging programs beyond the current year.

Ask FN2 about BDX next report

Transcript, numbers and history already loaded
What should I watch for in BDX's next earnings report?How did BDX guide last quarter, and is consensus above or below that?Give me the bull and bear case going into BDX earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the BDX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent BDX quarters

All BDX earnings
+5.9%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q2

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.